Invitrogen™ C9 Neoantigen Monoclonal Antibody (WU13-15)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA549003

Catalog No. FERMA549003

Description

C9 Neoantigen Monoclonal Antibody for Western Blot, ICC/IF, IHC (F), IHC (P), Flow, IA

C9 neoantigen is a target gene that is involved in the immune system's response to cancer cells. Neoantigens are proteins that are produced by cancer cells and are not present in normal cells. C9 neoantigen is a protein fragment that is produced when the C9 protein is broken down by enzymes in the cancer cells. The immune system recognizes these neoantigens as foreign and mounts an attack against the cancer cells. C9 neoantigen is being studied as a potential target for cancer immunotherapy, which involves using the patient's own immune system to fight cancer.

Specifications

• Antigen: C9 Neoantigen
• Classification: Monoclonal
• Concentration: 100 μg/mL
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide
• Gene Alias: C9
• Immunogen: The monoclonal antibody WU13-15 recognizes a neoepitope on the 61 kDa complement component C9, integrated in the terminal complement complex (TCC).
• Quantity: 100 μg
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG1

• Applications: Flow Cytometry, Inhibition Assays, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
• Clone: WU13-15
• Conjugate: Unconjugated
• Gene Accession No.: P29466, P48729, Q8N752
• Host Species: Mouse
• Purification Method: Protein G
• Regulatory Status: RUO
• Gene ID (Entrez): 122011, 1452, 834
• Content And Storage: 4°C
• Form: Liquid